Nasus Pharma NSRX
NYSE NSRX
$3.40 +0.16 (+4.65%)
As of: Oct 21, 2026 · 11:35 AM EDT

Nasus Pharma (NSRX) Assets (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Assets of $12.45 million for Q2 2026, compared with $639,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Assets of $5 million, up 597.9% from FY2024.

  • By year, Assets came in at $717,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 201.06 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 135.12 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 201.13 Bn
10 Nasus Pharma 27.23 Mn 10.53 Mn - 12.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.45 Mn
Dec 31, 2025 5.00 Mn
Jun 30, 2025 639,000.00
Dec 31, 2024 717,000.00
API Access

Nasus Pharma Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=NSRX&period=max&api_key=YOUR_API_KEY